BR Biomedical Reports 2049-9434 2049-9442 D.A. Spandidos 10.3892/br.2014.307 br-02-05-0709 Articles Catabolite control protein A is an important regulator of metabolism in Streptococcus suis type 2 LANGXULONG12 WANZHONGHAI12 BUZHAOYANG12 WANGXIURAN3 WANGXIAOXU12 ZHULINGWEI12 WANJIAYU12 SUNYANG12 WANGXINGLONG12 Institute of Military Veterinary, Academy of Military Medical Sciences, Jilin Agricultural University, Changchun, Jilin 130122, P.R. China Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Jilin Agricultural University, Changchun, Jilin 130122, P.R. China School of Life Science, Jilin Agricultural University, Changchun, Jilin 130122, P.R. China Correspondence to: Professor Xinglong Wang, Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Institute of Military Veterinary, Academy of Military Medical Sciences, 666 Liuying West Road, Changchun, Jilin 130122, P.R. China, E-mail: wangxl-2006@163.com 9 2014 30 06 2014 2 5 709 712 12 03 2014 06 06 2014 Copyright © 2014, Spandidos Publications 2014

Streptococcus suis (S. suis) type 2 is an extremely important Gram-positive bacterial pathogen that can cause human or swine endocarditis, meningitis, bronchopneumonia, arthritis and sepsis. Catabolite control protein A (CcpA) is a major transcriptional regulator in S. suis type 2 that functions in catabolite control, specifically during growth on glucose or galactose. The regulation of central metabolism can affect the virulence of bacteria. In the present study, a metabolomics approach was used along with principal components analysis (PCA) and partial least-squares-discriminant analysis (PLS-DA) models and 37 metabolites were found that differed substantially between native S. suis and a mutant lacking CcpA. These results showed that CcpA is an important protein in S. suis type 2 for studying bacterial protein function.

 Streptococcus suis type 2 carbon control protein A metabolomics Introduction

Streptococcus suis (S. suis) type 2 is an important Gram-positive bacterial pathogen of pigs that causes large economic losses in the meat industry, has a high rate of incidence and induces mortality worldwide (1,2).

Carbon catabolite repression (CCR) has a significant function in S. suis type 2 as it regulates the utilization of different carbon sources. CCR also affects the expression of numerous virulence factors that are dependent on the quantity and type of carbohydrates present (3,4). Catabolite control protein A (CcpA) is the major regulator of CCR in Gram-positive bacteria and is also involved in the regulation of virulence factors (5). Transcriptomic studies that compare native and mutant strains are a powerful approach for studying the regulation of carbohydrate metabolism and virulence (6). A previous study has shown that the mutation of CcpA leads to altered biofilm phenotypes in Streptococcus mutans (S. mutans) and other oral streptococci (7). CcpA was suggested to function in the regulation of virulence in numerous Gram-positive pathogens, particularly streptococci (8,9).

Our previous study systematically analyzed the virulence in S. suis type 2 using proteomics and found that CcpA is an important protein in this organism (10). In the present study, a metabolomics experiments was performed to identify the proteins and metabolites that differed in S. suis type 2 CcpA mutant strains. These results confirmed the importance of this protein in the organism.

 Materials and methods Bacterial strains and culture conditions

Native S. suis type 2 and CcpA mutant strains were cultured in Todd-Hewitt broth (Oxoid Ltd., Basingstoke, Hampshire, UK) with 5% CO2 at 37°C. This procedure was conducted to prepare cultures in the exponential growth phase for the subsequent experiments.

 Metabolomics methodology and analysis

Quenching of the S. suis culture for the metabolomics experiments was performed by adding 60% MeOH and 0.85% (w/v) ammonium carbonate (pH 5.5). Centrifugation was performed at 10,000 × g for 2 min. The supernatants were then frozen in liquid nitrogen, freeze-dried and stored at −80°C until they were required for subsequent analysis. The regulation of amino acid metabolism by CcpA was detected using liquid chromatography-mass spectrometry (LC-MS)-based metabolomic methods. The results were analyzed using MassHunter software (version B.03.01) from Agilent Technologies, Inc. (Santa Clara, CA, USA). The principal components analysis (PCA) and partial least squares-discriminant analysis (PLS-DA) were performed with the SIMCA-P software package (Umetrics, Inc., Umea, Sweden). The differentially expressed compounds were distinguished by P<0.05, which was considered to indicate a statistically significant difference (11,12). The metabolomics methods and analysis used in the study were carried out by Shanghai Sensichip Infotech Co., Ltd. (Shanghai, China).

 Results Differences in metabolites between the bacterial strains

PCA and PLS-DA were used to analyze the metabolomics data. There was little overlap with the PCA model, suggesting this was appropriate for use in the present study. However, it was determined that PLS-DA should be used as the main model for analyzing the metabolomics samples as previously described (13). Based on the PLS-DA models, the native S. suis type 2 and CcpA mutant strains were successfully discriminated, with an R2X value of 0.439 and a Q2 value of 0.924 in the electrospray ionization (ESI)+ model using variable importance in the projection (VIP) of the first and second principal components (t[1] and t[2], respectively). An R2X value of 0.452 and a Q2 value of 0.878 were obtained with the ESI- model (Fig. 1). Using the T-test on the PLS-DA model, 37 differential metabolites were identified with a VIP score >1 (Table I). The model analysis suggested that the main differences were for the metabolites that were involved in amino acid, nucleic acid and fat metabolism, which all occur in the liver.

 Discussion

S. suis type 2 is persistent in a wide variety of environmental conditions and this contributes to the serious economic losses endured by the swine industry when disease outbreaks occur. Another major concern to public health is the elusive mechanisms of invasion and infection, which remain to be clarified (14,15). CcpA-independent CCR appears to be important for the coordination of carbohydrate catabolism in this organism. The ability to integrate information regarding the metabolic status of the cells with a knowledge of the transcriptional responses would be advantageous. The mechanisms of catabolite control by CcpA have been studied in model bacteria previously (6). Transcriptomics and microarray studies have shown that this protein regulates carbohydrate metabolism in S. mutans (6). The deletion of CcpA substantially reduced the effects of repressing sugars on α- or β-glucosidase activity. CcpA regulates several proteins that are involved in metabolism, a number of which are important for bacterial colonization, survival or replication in vivo (16). CcpA is part of a conserved pathway in Gram-positive bacteria that controls sugar utilization, and targeting this protein or pathway is an attractive mechanism for diminishing virulence (17).

CcpA also affects sugar metabolism and virulence in S. suis type 2 and mutant strains lacking this protein exhibit a reduced expression of certain virulence genes, including sly and eno (1). CcpA is considered to regulate virulence factors through the expression of genes in the capsule locus (18). This is reminiscent of a functional study in Streptococcus pneumoniae, which showed that CcpA is a master regulator of catabolism and virulence (19). A notable impact on the capsule synthesis and virulence properties of S. suis has also been shown (20).

The LC-MS-based metabolomics experiments in the present study suggested that CcpA is involved in the regulation of amino acid metabolism, which may affect the metabolic fitness and is in accordance with the findings of other studies (21). The PLS-DA model showed that CcpA acts as a regulator of catabolite control, and has a particular influence on the metabolism of sugars, fats and amino acids.

The experiments also showed that CcpA is an important regulator of metabolism in S. suis type 2. Additionally, the analysis of the metabolomics results identified numerous metabolites, including ABC transporters, amino sugars, carbon metabolism, glycolysis and galactose metabolism. This result indicates that CcpA may be involved in mediating metabolic networks and coordinating the regulation of catabolism and anabolism to ensure optimum growth and propagation under particular growth conditions. Notably, Bacillus subtilis mutants lacking CcpA have a slower growth rate than native bacteria in minimal media containing glucose and ammonium as carbon and nitrogen sources (22,23). This result suggests that CcpA may regulate carbon and nitrogen metabolic pathways and function in connecting catabolism and anabolism.

From the data of the metabolomics analyses, it was found that glutamate, glutamine and other deviants and enzymes have different effects between the native S. suis type 2 and CcpA mutant strains. These, and other genes, were found to have extremely important effects for the methionine acquisition and synthesis of Streptococcus pneumoniae in the growth and virulence when using gene deletions methods (24). By contrast, the methionine aminopeptidase is a dinuclear metalloprotease, which is conserved in all forms of life in bacteria (25). Others, including the glutamine, glutamate and uridine biosynthesis and transport, are stringently controlled during bacteria metabolism (26–28). Thus, these results may provide a clear insight into the regulation of glutamine and glutamate metabolism or another mechanism of S. suis type 2 mediated by CcpA.

In conclusion, the metabolomics analyses performed in the present study proved useful for studying bacterial protein function. CcpA was found to affect numerous metabolic pathways in S. suis. The apparent associations with the metabolism of sugars, amino acids, amino sugars, nucleotides and ABC transporters are potentially noteworthy. However, more studies are required to confirm and understand these phenomena.

 Acknowledgements

The metabolomics experiments and analysis were performed by the Shanghai Sensichip Infotech Co., Ltd. (Shanghai, China). The present study was funded by the National Natural Science Foundation of China (grant nos. 31101790/C1803 and 31172340/C180501)

 References WillenborgJFuldeMde GreeffARohdeMSmithHEValentin-WeigandPGoetheRRole of glucose and CcpA in capsule expression and virulence of Streptococcus suisMicrobiology157182318332011 ZhangJZhuJRenHZhuSZhaoPZhangFLvHHuDHaoLGengMRapid visual detection of highly pathogenic Streptococcus suis serotype 2 isolates by use of loop-mediated isothermal amplificationJ Clin Microbiol51325032562013 GörkeBStülkeJCarbon catabolite repression in bacteria: many ways to make the most out of nutrientsNat Rev Microbiol66136242008 DeutscherJThe mechanisms of carbon catabolite repression in bacteriaCurr Opin Microbiol1187932008 WarnerJBLolkemaJSCcpA-dependent carbon catabolite repression in bacteriaMicrobiol Mol Biol Rev674754902003 AbranchesJNascimentoMMZengLBrowngardtCMWenZTRiveraMFBurneRACcpA regulates central metabolism and virulence gene expression in Streptococcus mutansJ Bacteriol190234023492008 ZhengLChenZItzekAAshbyMKrethJCatabolite control protein A controls hydrogen peroxide production and cell death in Streptococcus sanguinisJ Bacteriol1935165262011 CarvalhoSMKloostermanTGKuipersOPNevesARCcpA ensures optimal metabolic fitness of Streptococcus pneumoniaePLoS One6e267072011 LeibaJHartmannTCluzelMECohen-GonsaudMDelolmeFBischoffMMolleVA novel mode of regulation of the Staphylococcus aureus catabolite control protein A (CcpA) mediated by Stk1 protein phosphorylationJ Biol Chem28743607436192012 WangYDangYWangXLuHWangXLangXLiXFengSZhangFRenL Comparative proteomic analyses of Streptococcus suis serotype 2 cell wall-associated proteinsCurr Microbiol625785882011 TengQHuangWLColletteTWEkmanDRTanCA direct cell quenching method for cell-culture based metabolomicsMetabolomics51992082009 ChenFXueJZhouLWuSChenZIdentification of serum biomarkers of hepatocarcinoma through liquid chromatography/mass spectrometry-based metabonomic methodAnal Bioanal Chem401189919042011 CarrolaJRochaCMBarrosASGilAMGoodfellowBJCarreiraIMBernardoJGomesASousaVCarvalhoLDuarteIFMetabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urineJ Proteome Res102212302011 Berthelot-HéraultFGottschalkMLabbéACarioletRKobischMExperimental airborne transmission of Streptococcus suis capsular type 2 in pigsVet Microbiol8269802001 JiangHFanHJLuCPIdentification and distribution of putative virulent genes in strains of Streptococcus suis serotype 2Vet Microbiol1333093162009 IyerRBaligaNSCamilliACatabolite control protein A (CcpA) contributes to virulence and regulation of sugar metabolism in Streptococcus pneumoniaeJ Bacteriol187834083492005 TangYWuWZhangXLuZChenJFangWCatabolite control protein A of Streptococcus suis type 2 contributes to sugar metabolism and virulenceJ Microbiol5099410022012 SeidlKStuckiMRueggMGoerkeCWolzCHarrisLBerger-BächiBBischoffMStaphylococcus aureus CcpA affects virulence determinant production and antibiotic resistanceAntimicrob Agents Chemother50118311942006 KaufmanGEYotherJCcpA-dependent and -independent control of beta-galactosidase expression in Streptococcus pneumoniae occurs via regulation of an upstream phosphotransferase system-encoding operonJ Bacteriol189518351922007 ZhangAChenBYuanZLiRLiuCZhouHChenHJinMHP0197 contributes to CPS synthesis and the virulence of Streptococcus suis via CcpAPLoS One7e509872012 LiJHuangCZhengDWangYYuanZCcpA-mediated enhancement of sugar and amino acid metabolism in Lysinibacillus sphaericus by NMR-based metabolomicsJ Proteome Res11465446612012 LudwigHMeinkenCMatinAStülkeJInsufficient expression of the ilv-lew operon encoding enzymes of branched-chain amino acid biosynthesis limits growth of a Bacillus subtilis ccpA mutantJ Bacteriol184517451782002 FujitaYCarbon catabolite control of the metabolic network in Bacillus subtilisBiosci Biotechnol Biochem732452592009 BasavannaSChimalapatiSMaqboolARubboBYusteJWilsonRJHosieAOgunniyiADPatonJCThomasGBrownJSThe effects of methionine acquisition and synthesis on Streptococcus pneumoniae growth and virulencePLoS One8e496382013 AryaTKishorCSaddanapuVReddiRAddlagattaADiscovery of a new genetic variant of methionine aminopeptidase from Streptococci with possible post-translational modifications: biochemical and structural characterizationPLoS One8e752072013 HendriksenWTKloostermanTGBootsmaHJEstevãoSde GrootRKuipersOPHermansPWSite-specific contributions of glutamine-dependent regulator GlnR and GlnR-regulated genes to virulence of Streptococcus pneumoniaeInfect Immun76123012382008 ChenPMChenYYYuSLSherSLaiCHChiaJSRole of GlnR in acid-mediated repression of genes encoding proteins involved in glutamine and glutamate metabolism in Streptococcus mutansAppl Environ Microbiol76247824862010 KloostermanTGHendriksenWTBijlsmaJJBootsmaHJvan HijumSAKokJHermansPWKuipersOPRegulation of glutamine and glutamate metabolism by GlnR and GlnA in Streptococcus pneumoniaeJ Biol Chem28125097251092006

(A and B) Principal components analysis (PCA) and (C and D) partial least squares-discriminant analysis (PLS-DA) score plots derived from liquid chromatography-mass spectrometry results. (A and C) Electrospray ionization (ESI)+ model and (B and D) ESI- model. Rhombuses, native Streptococcus suis type 2; squares, catabolite control protein A mutant strain.

Metabolite differences between native Streptococcus suis type 2 and CcpA mutant strains.

LC-MS Retention time, min Molecular mass Metabolite VIP scorea Fold changeb
ESI+ 0.66 103.0631 γ-aminobutryic acid 1.98 0.58
0.68 165.0456 S-oxide 1.55 0.29
0.68 147.0527 L-glutamate 1.98 0.42
0.74 159.1260 DL-2-aminooctanoic acid 1.28 −0.45
0.74 453.2959 Glycerophospho-N-palmitoyl ethanolamine 1.83 −2.38
0.82 149.0509 L-methionine 1.84 1.63
1.02 244.0703 Uridine 1.91 −1.56
1.08 267.0971 Deoxyguanosine 2.29 3.20
1.16 573.1530 Biotinyl-5′-AMP 1.74 −2.28
1.17 268.0795 Inosine 1.67 −0.98
3.72 441.2594 Leukotriene E3 1.28 −0.61
10.14 255.2567 Palmitic amide 1.73 −0.63
10.65 329.2575 4,8-Dimethylnonanoyl-carnitine 2.24 0.95
13.44 281.2723 Oleamide 1.88 0.54
13.93 160.0887 Homoglutamine 1.77 0.35
15.26 384.2865 17,20-Dimethyl prostaglandin F1α 1.84 0.76
16.07 148.0376 2-Hydroxyglutarate 2.21 0.88
ESI− 0.67 133.0378 L-aspartic acid 1.76 0.32
0.68 147.0535 L-glutamate 1.63 0.44
0.70 183.0656 Phosphocholine 1.82 1.19
0.74 151.0504 Guanine 1.77 1.42
0.75 324.0371 Uridine monophosphate 1.95 1.89
1.00 168.0285 Uric acid 1.36 −0.97
1.00 152.0336 Xanthine 1.46 0.36
1.02 244.0707 Uridine 1.56 −0.58
1.05 192.0272 Citric acid 1.64 −2.85
1.16 268.0820 Inosine 1.67 −1.86
1.17 118.0266 Succinic acid 1.52 −0.15
1.23 131.0948 L-leucine 1.47 −0.82
3.80 204.0905 L-tryptophan 1.53 −0.25
3.93 427.2449 20-Hydroxy N-arachidonoyl taurine 1.33 −0.22
4.80 643.3191 Gsh-prostaglandin A1 1.86 −0.32
4.93 723.3088 Trypanothione 1.52 −0.71
5.62 187.1212 8-Amino-7-oxononanoic acid 1.35 0.68
5.83 193.0742 Phenylacetylglycine 1.61 −1.14
11.72 450.1830 Geranylgeranyl PP 1.54 0.73
14.44 166.0484 7-Methylxanthine 1.53 1.53

VIP, variable importance in the projection (P<0.05).

Fold change was calculated as binary logarithm of average mass response ratio between native Streptococcus suis type 2 and CcpA mutant strain, where the positive value means that the native Streptococcus suis type 2 of the metabolite is larger than the CcpA mutant strain.

CcpA, catabolite control protein A; LC-MS, liquid chromatography-mass spectrometry; ESI, electrospray ionization.